Cervical Cancer News and Research

RSS

Cancer is a disease in which cells in the body grow out of control. Cancer is always named for the part of the body where it starts, even if it spreads to other body parts later. When cancer starts in the cervix, it is called cervical cancer. The cervix is the lower, narrow end of the uterus. Also known as the womb, the uterus is where a baby grows when a woman is pregnant. The cervix connects the upper part of the uterus to the vagina (birth canal).

Cervical cancer is highly preventable in most Western countries because screening tests and a vaccine to prevent HPV infections are available. When cervical cancer is found early, it is highly treatable and associated with long survival and good quality of life.

Cancer Research Technology licenses novel cancer diagnostic markers

Cancer Research Technology Limited announced today that they have entered into a worldwide license agreement with TriPath Imaging, Inc.

22 Aug 2005

Proportion of high-risk HPV infections preventable by vaccine may vary by region

Vaccines currently being developed against two types of virus that cause cervical cancer - HPV16 or HPV18 - may prevent a larger proportion of high-risk HPV infections in Europe than sub-Saharan Africa, suggests a study being published online by The Lancet.

16 Aug 2005

Enzyme called matriptase, when left to its own devices, can cause cance

Scientists at the National Institute of Dental and Craniofacial Research (NIDCR) and colleagues report in animal studies that a single, scissor-like enzyme called matriptase, when left to its own devices, can cause cancer.

16 Aug 2005

Obese people are less likely to receive preventive services such as mammograms, Pap smears and flu shots

The Duke study showed that, for a sample of white middle-aged women, as body mass index (BMI) went up, the odds of receiving mammograms and Pap smears went down.

3 Aug 2005

Researchers have identified a pathway that is specific for cancer

When cancer spreads, people often die. That's why a lot of cancer research and drugs focus on the metabolic pathways that allow cancer to metastasize -- to spread from one part of the body to another.

1 Aug 2005

Human papillomavirus (HPV) genotyping can benefit clinical practice

A study published in the current issue of the Journal of the National Cancer Institute (JNCI) concludes that genotyping of specific high-risk types of the human papillomavirus (HPV), the cause of virtually all cases of cervical cancer, can benefit clinical practice by enabling more focused attention on women who are at highest risk, announced Digene Corporation.

26 Jul 2005

High rates of cervical cancer are indicators of larger problems in access to health care

The report also finds that cervical cancer mortality, which is higher in certain geographic areas and populations, is a marker for other health disparities.

21 Jul 2005

Northerners in the UK more prone to certain cancers

According to the office for National Statistics (ONS) ' "Cancer Atlases" for the 1990s, people in the north of England and Scotland are far more likely to get certain cancers than those living in the south.

11 Jul 2005

Bacteria linked to oral cancer

A new study has found that the most common form of oral cancer, is linked to three different types of mouth bacteria.

11 Jul 2005

Why cervical precancers disappear in some women and not in others

New research sheds light on why cervical precancers disappear in some women and not in others. Scientists at the Johns Hopkins Kimmel Cancer Center report in the July 1 issue of Clinical Cancer Research that the reason many of these lesions persist is an unlikely mix of human papilloma virus (HPV) strain and a woman's individual immune system.

6 Jul 2005

Research sheds light on why cervical precancers disappear in some women and not in others

New research sheds light on why cervical precancers disappear in some women and not in others. Scientists say the reason many of these lesions persist is an unlikely mix of human papilloma virus (HPV) strain and a woman’s individual immune system.

4 Jul 2005

New legislation provides women 40 to 49 with free mammograms

The Pennsylvania House of Representatives has passed HB1606 by a unanimous vote of 197-0. This legislation, known as the Women's Breast and Cervical Cancer Early Screening Act, provides women aged 40 to 49,access to free mammograms.

4 Jul 2005

Medical experts say that yearly checkup not necessary - doctors and patients disagree

Though you and your doctor might think that yearly checkup is just a routine part of staying healthy, that practice isn't endorsed by a panel of experts.

29 Jun 2005

AAV2 has great potential to be developed as an anti-cancer agent

Six days is all it takes for a common, non-disease-causing virus to kill cervical, breast, prostate and squamous cell cancer cells in laboratory cultures, according to Penn State College of Medicine researchers.

21 Jun 2005

Indigenous health gap wider in New Zealand

The health gap between Maori and European New Zealanders is wider than that between American Indians and the US majority white population in the United States, a researcher from The University of Auckland has found.

16 Jun 2005

Incorporating human papillomavirus testing into cervical cancer screening will provide health benefits at a reasonable cost

Incorporating testing for human papillomavirus (HPV) DNA into cervical cancer screening has the potential for improving health benefits at a reasonable cost in France, Italy, the Netherlands, and the United Kingdom, according to a new study in the June 15 issue of the Journal of the National Cancer Institute.

14 Jun 2005

Researchers may be on the verge of exploiting the vulnerabilities of a virus that causes cervical cancer

Researchers may be on the verge of exploiting the vulnerabilities of a virus that causes cervical cancer, thanks to a newly developed technique that enables scientists to mass-produce human papillomavirus (HPV) in the laboratory.

13 Jun 2005

Research accelerates the search for an effective cancer vaccine

By devising a novel way to package the genome of a common human tumor virus - the virus that causes common warts, genital warts and that is implicated in prevalent cancers - scientists have paved the way for making the pathogen far more accessible to biomedical science.

13 Jun 2005

Helix opens additional sites for its Topical Interferon Alpha-2b Phase II clinical study

Helix BioPharma announced today the opening of two additional German sites for the Phase II clinical trial of its Topical Interferon Alpha-2b product at the Charité Berlin, one of the largest university hospitals in Europe.

2 Jun 2005

Harmful chemicals may reprogram gene response to estrogen

New research shows that exposure to harmful chemicals and drugs during critical developmental periods early in life may actually "reprogram" the way certain genes respond to the female hormone estrogen. This genetic reprogramming may determine whether people with a genetic predisposition for a disease actually develop the disease.

1 Jun 2005